IQVIA COVID-19 Vaccine Revenues To Soar But Pandemic Will Impact Overall Global Medicine Spending
While more money will be poured into COVID-19 vaccines, the pandemic's effects will be felt on overall growth of global medicine use following disruptions to patient engagement with healthcare, a new report from the IQVIA Institute for Human Data Science predicts.
You may also be interested in...
Clinical trial initiations in cell and gene therapies and immuno-oncology are seeing a spike as the COVID-19 experience has shown the benefits of beginning research early, Parexel’s executive vice president says. In an interview with Scrip, Sanjay Vyas discusses a range of topics from diversity to the advantages of block chain and growth in China
Emerging Company Profile: Cybin’s novel approach to psilocybin therapeutics aims for better safety, shorter duration and less variability through the process of deuteration.
The company insists it will reconsider the price of Aduhelm if the market turns out to be larger than Biogen anticipates, but big price reductions for branded drugs are rare.